| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $49.6M | -42.4% |
| SG&A Expense | $32.6M | -12.7% |
| Operating Income | -$82.2M | +33.4% |
| Net Income | -$73.8M | +38.9% |
| EPS (Basic) | -$1.85 | +49.3% |
| EPS (Diluted) | -$1.85 | +49.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.7M | -94.6% |
| Short-term Investments | $109.6M | — |
| Current Assets | $124.6M | -33.2% |
| Total Assets | $173.7M | -17.8% |
| Current Liabilities | $25.8M | -18.6% |
| Total Liabilities | $48.0M | -5.0% |
| Stockholders' Equity | $125.7M | -21.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$70.7M | +20.8% |
| Capital Expenditures | $6.7M | +5.1% |
| Investing Cash Flow | -$104.8M | -1538.5% |
| Financing Cash Flow | $5.9M | +3139.9% |
| Free Cash Flow | -$77.4M | +19.1% |